The 10th Anniversary of our flagship event, Drug Discovery, will this year take place at ACC in Liverpool, UK, located in the heart of the city beside the historic Albert Docks, from 13th-14th October 2016.
ELRIG Drug Discovery is the premier meeting place in Europe for scientists from industry, biotech and academia engaged in pre-clinical drug discovery. First established in Nottingham in 2006, the meeting this year expects over 1,200 delegates and 80 exhibiting companies, bringing together world-leading scientists to discuss cutting-edge advances in the application of laboratory technology, disease biology, and development of novel chemical and biological candidate drugs.
The 2016 program will include exciting sessions on the development of new medicines in oncology and immunotherapy, the application of innovative technologies in assay development, drug screening and chemistry and the application of new technologies to identify and validate drug targets. New for this year is a track discussing ground-breaking developments in the use of cells as biological tools and therapeutics.
In the ten years since the first Drug Discovery meeting, the industry has grown exponentially, with technological advances in early drug discovery and its clinical applications putting life sciences at the epicentre of drug and gene therapies. Through collaborations with experts from industry and academia along with the backing of some global pharmaceutical organisations, ELRIG continues to provide free-to-attend meetings which are accessible to all.